Immuno-Oncology Panels Gallery

CD68, CD163, PanCK, PD-L1">

CD68, CD163, PanCK, PD-L1

Gallbladder Adenocarcinoma

p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1). Two-panel overlay,
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV+ p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1)

Head & Neck Squamous Cell Carcinoma

p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2). Two-panel overlay,
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV+ p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2)

Head & Neck Squamous Cell Carcinoma

p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1). Two-panel overlay,
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1)

Head & Neck Squamous Cell Carcinoma

p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2). Two-panel overlay,
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2)

Head & Neck Squamous Cell Carcinoma

p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (3). Two-panel overlay,
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (3)

Head & Neck Squamous Cell Carcinoma

PD-L1, PanCK.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PD-L1, PanCK

Head & Neck Squamous Cell Carcinoma

CD4, CD8, PD-1, PanCK.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, CD8, PD-1, PanCK

Head & Neck Squamous Cell Carcinoma

CD68, CD163, PanCK, PD-L1 (1).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD68, CD163, PanCK, PD-L1 (1)

Head & Neck Squamous Cell Carcinoma

CD68, CD163, PanCK, PD-L1 (2).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD68, CD163, PanCK, PD-L1 (2)

Head & Neck Squamous Cell Carcinoma

CD4, CD8, FoxP3, Tbet">

CD4, CD8, FoxP3, Tbet

Luminal B Breast Cancer

HER2, ER, PR, Ki-67, CD3, CD4, CD8. Two-panel overlay.">

HER2, ER, PR, Ki-67, CD3, CD4, CD8

Luminal B Breast Cancer

HER2, ER, PR, Ki-67">

HER2, ER, PR, Ki-67

Luminal B Breast Cancer

CD68, CD163, PanCK, PD-L1">

CD68, CD163, PanCK, PD-L1

Lung Adenocarcinoma

CK5, Vimentin, EGFR, Ki-67">

CK5, Vimentin, EGFR, Ki-67

Pancreatic Ductal Adenocarcinoma

CD4, CD8, FoxP3, PD-1">

CD4, CD8, FoxP3, PD-1

Stomach Adenocarcinoma

CD4, CD8, FoxP3, PD-1">

CD4, CD8, FoxP3, PD-1

Thyroid Gland Papillary Carcinoma

CD68, CD163, PanCK, PD-L1">

CD68, CD163, PanCK, PD-L1

Thyroid Gland Papillary Carcinoma

CD4, CD8, FoxP3, Tbet">

CD4, CD8, FoxP3, Tbet

Triple-Negative Breast Cancer

Ki-67, CD8, CD4, CD31 20x">

Ki-67, CD8, CD4, CD31 20x

Triple-Negative Breast Cancer

Ki-67, CD8, CD4, CD31 5x">

Ki-67, CD8, CD4, CD31 5x

Triple-Negative Breast Cancer

CD3, CD20, PD-L1, CK5">

CD3, CD20, PD-L1, CK5

Triple Negative Breast Cancer

EGFR, Vimentin, CK5, Ki-67, CD3, CD4, CD8. Two-panel overlay.">

EGFR, Vimentin, CK5, Ki-67, CD3, CD4, CD8

Triple Negative Breast Cancer

EGFR, CK5, Ki-67, CD3, CD4, CD8, CD20. Two-panel overlay.">

EGFR, CK5, Ki-67, CD3, CD4, CD8, CD20

Triple Negative Breast Cancer

CD68, CD163, PanCK, PD-L1">

CD68, CD163, PanCK, PD-L1

Uterine Cervix Squamous Cell Carcinoma

Cell IDx is a Registered Supplier on and